Electrical vagus nerve stimulation for the treatment of chronic heart failure

Cleveland Clinic Journal of Medicine

Volumn 78, Issue SUPPL. 1, 2011, Pages

  Sabbah, Hani N ^a  

^a HENRY FORD HEART AND VASCULAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYTOKINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ARTICLE; AUTONOMIC NEUROPATHY; CHOLINERGIC SYSTEM; HEART FAILURE; HEART VENTRICLE REMODELING; HUMAN; INFLAMMATION; PATHOLOGY; VAGUS NERVE STIMULATION;

ADRENERGIC BETA-ANTAGONISTS; AUTONOMIC NERVOUS SYSTEM DISEASES; CYTOKINES; HEART FAILURE; HUMANS; INFLAMMATION; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PARASYMPATHETIC NERVOUS SYSTEM; VAGUS NERVE STIMULATION; VENTRICULAR REMODELING;

EID: 84858626216     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.78.s1.04     Document Type: Article

References (33)

1. Schwartz PJ, Vanoli E, Stramba-Badiale M, De Ferrari GM, Billman GE, Foreman RD. Autonomic mechanisms and sudden death. New insights from analysis of baroreceptor reflexes in conscious dogs with and without myocardial infarction. Circulation 1988; 78:969-979.
2. Mortara A, La Rovere MT, Pinna GD, et al. Arterial baroreflex modulation of heart rate in chronic heart failure: clinical and hemodynamic correlates and prognostic implications. Circulation 1997; 96:3450-3458.
3. La Rovere MT, Bigger JT Jr, Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heartrate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) investigators. Lancet. 1998; 351:478-484.
4. Lechat P, Hulot JS, Escolano S, et al. Heart rate and cardiac rhythm relationships with bisoprolol benefi t in chronic heart failure in CIBIS II trial. Circulation 2001; 103:1428-1433.
5. Sabbah HN, Shimoyama H, Kono T, et al. Effects of longterm monotherapy with enalapril, metoprolol and digoxin on the progression of left ventricular dysfunction and dilation in dogs with reduced ejection fraction. Circulation 1994; 89:2852-2859.
6. Sabbah HN, Stanley WC, Sharov VG, et al. Effects of dopamine β-hydroxylase inhibition with nepicastat on the progression of left ventricular dysfunction and remodeling in dogs with chronic heart failure. Circulation 2000; 102:1990-1995.
7. Cheng Y, George I, Yi GH, et al. Bradycardic therapy improves left ventricular function and remodeling in dogs with coronary embolizationinduced chronic heart failure. J Pharmacol Exp Ther 2007; 321:469-476.
8. Swedberg K, Komajda M, Bohm M, et al, on behalf of the SHIFT Investigators. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebocontrolled study. Lancet 2010; 376:875-885.
9. Kunze DL. Reflex discharge patterns of cardiac vagal efferent fibres. J Physiol 1972; 222:1-15.
10. Harman MA, Reeves TJ. Effects of vagus nerve stimulation on atrial and ventricular function. Am J Physiol 1968; 215:1210-1217.
11. Vanoli E, De Ferrari GM, Stramba-Badiale M, Hull SS Jr, Foreman RD, Schwartz PJ. Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. Circ Res 1991; 68:1471-1481.
12. Li M, Zheng C, Sato T, Kawada T, Sugimachi N, Sunagawa K. Vagal nerve stimulation markedly improves longterm survival after chronic heart failure in rats. Circulation 2004; 109:120-124.
13. Zheng C, Li M, Inagaki M, Kawada T, Sunagawa K, Sugimachi M. Vagal stimulation markedly suppresses arrhythmias in conscious rats with chronic heart failure after myocardial infarction. Conf Proc IEEE Eng Med Biol Soc 2005; 7:7072-7075.
14. Sabbah HN, Stein PD, Kono T, et al. A canine model of chronic heart failure produced by multiple sequential coronary microembolizations. Am J Physiol 1991; 260:H1379-H1384.
15. Zhang Y, Popovic ZB, Bibevski S, et al. Chronic vagus nerve stimulation improves autonomic control and attenuates systemic infl ammation and heart failure progression in a canine highrate pacing model. Circ Heart Fail 2009; 2:692-699.
16. De Ferrari GM, Crijns HJ, Borggrefe M, et al, on behalf of CardioFit Multicenter Trial Investigators. Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure. Eur Heart J 2011; 32:847-855.
17. Sabbah HN, Rastogi S, Mishra S, et al. Longterm therapy with neuroselective electric vagus nerve stimulation improves LV function and attenuates global LV remodelling in dogs with chronic heart failure. Eur J Heart Fail Supplements 2005; 4(suppl):166-167. Abstract 744.
18. Sabbah HN, Imai M, Zaretsky A, et al. Therapy with vagus nerve electrical stimulation combined with betablockade improves left ventricular systolic function in dogs with heart failure beyond that seen with betablockade alone. Eur J Heart Fail Supplements 2007; 6(suppl):114. Abstract 509.
19. Liu YH, Yang XP, Sharov VG, et al. Effects of angiotensinconverting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors. J Clin Invest 1997; 99:1926-1935.
20. Wang H, Yu M, Ochani M, et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 2003; 421:384-388.
21. Sabbah H, Rastogi S, Mishra S, Imai M, Gupta RC. Chronic therapy with neuroselective electric vagus nerve stimulation attenuates mRNA expression of proinfl ammatory cytokines in dogs with heart failure. Eur Heart J Suppl 2005; 26(suppl 1):65.
22. Feng Q, Song W, Lu X, et al. Development of heart failure and congenital septal defects in mice lacking endothelial nitric oxide synthase. Circulation 2002; 106:873-879.
23. Kelly RA, Balligand JL, Smith TW. Nitric oxide and cardiac function. Circ Res 1996; 79:363-380.
24. Mungrue IN, Gros R, You X, et al. Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death. J Clin Invest 2002; 109:735-743.
25. Damy T, Ratajczak P, Shah AM, et al. Increased neuronal nitric oxide synthasederived NO production in the failing human heart. Lancet 2004; 363:1365-1367.
26. Bendall JK, Damy T, Ratajczak P, et al. Role of myocardial neuronal nitric oxide synthasederived nitric oxide in β-adrenergic hyporesponsiveness after myocardial infarctioninduced heart failure in rat. Circulation 2004; 110:2368-2375.
27. Gupta RC, Mishra S, Rastogi S, Imai M, Zaca V, Sabbah HN. Chronic therapy with electric vagus nerve stimulation normalizes mRNA and protein expression of nitric oxide synthase in myocardium of dogs with heart failure. Eur Heart J 2006; 27:477. Abstract.
28. Severs NJ, Bruce AF, Dupont E, Rothery S. Remodelling of gap junctions and connexin expression in diseased myocardium. Cardio vasc Res 2008; 80:9-19.
29. Wang XJ, Gerdes AM. Chronic pressure overload cardiac hypertrophy and failure in guinea pigs: III. Intercalated disc remodeling. J Mol Cell Cardiol 1999; 31:333-343.
30. Ai X, Pogwizd M. Connexin 43 downregulation and dephosphorylation in nonischemic heart failure is associated with enhanced colocalized protein phosphatase type 2A. Circ Res 2005; 96:54-63.
31. Rastogi S, Mishra S, Ilsar I, Zaretsky A, Sabbah HN. Chronic therapy with electric vagus nerve stimulation normalizes mRNA and protein expression of connexin-40,-43 and-45 in left ventricular myocardium of dogs with heart failure. Circulation 2007; 116:II_218. Abstract 1089.
32. Adamson PB, Smith AL, Abraham WT, et al. Continuous autonomic assessment in patients with symptomatic heart failure: prognostic value of heart rate variability measured by an implanted cardiac resynchronization device. Circulation 2004; 110:2389-2394.
33. Sabbah HN, Ilsar I, Zaretsky A, Rastogi S, Wang M, Gupta RC. Vagusnerve stimulation in experimental heart failure. Heart Fail Rev 2011; 16:171-178.